<DOC>
	<DOCNO>NCT01589549</DOCNO>
	<brief_summary>A randomised study corticosteroid therapy without mesenchymal stromal cell therapy newly diagnose acute graft versus host disease bone marrow transplantation donor lymphocyte therapy . It hypothesise mesenchymal stromal cell therapy superior</brief_summary>
	<brief_title>Mesenchymal Stromal Cells Acute Graft Versus Host Disease</brief_title>
	<detailed_description>Patients newly diagnose untreated acute graft versus host disease grade 2-4 receive methylprednisolone 2.5mg/kg intravenously randomise receive receive allogeneic human mesenchymal stromal cell 2X10E6 intravenously two occasion weekly interval</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<criteria>Grades 24 acute graft versus host disease bone marrow transplantation day +180 transplantation Age 1855 year Must receive calcineurin inhibitor Failure sign inform consent Corticosteroid therapy 72 hour great ECOG score equal great 3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Acute graft versus host disease</keyword>
	<keyword>Bone marrow transplantation</keyword>
	<keyword>Mesenchymal stromal cell</keyword>
</DOC>